Molina Healthcare Schedules Q3 2026 Earnings Release as Q2 Guidance Revised Upwards

Molina Healthcare (NYSE: MOH) has set its third‑quarter 2026 earnings release for after the market closes on Wednesday, October 21, 2026, with a conference call scheduled for Thursday, October 22 at 8 a.m. EDT.

In its second quarter financial results, published in late July, Molina reported premium revenue of approximately $10.2 billion and served around 4.9 million members. GAAP diluted earnings per share came in at $1.19, while adjusted diluted EPS was $1.51. GAAP net income for the quarter was $60 million, with adjusted net income reaching $77 million.

The company raised its full‑year 2026 guidance, now targeting at least $2.15 per diluted share on a GAAP basis and at least $5.25 on an adjusted basis. The revised outlook reflects stronger-than-anticipated performance in Medicaid and Medicare, though Marketplace pressures offset gains in that segment. Management cautioned that earnings will face headwinds from the launch of a new Florida Medicaid contract in Q4 and ongoing MAPD business exit effects.

Why This Matters

Scheduling the Q3 earnings release and call signals that Molina is on track to deliver a key update to investors on its turnaround strategy and margin recovery efforts. The raised guidance for 2026, boosted by tighter medical cost control and rate improvements, suggests improved near-term profitability and reinforces the narrative that 2026 is a trough year for Medicaid pretax margins.

Investors will closely watch trends in medical care ratios across segments, membership trajectory, and the impact of the Florida Medicaid rollout as these factors will influence 2027 outlook. The company’s positioning in managed Medicaid and Medicare duals remains central to its strategic growth narrative, while challenges in Marketplace performance bear scrutiny.

MOH shares are trading at $196.30 as of September 8, 2026, down 1.1% for the day. While no causal linkage between company guidance and intraday market movement has been confirmed, the upcoming earnings call represents a pivotal event for investors assessing Molina’s path beyond a margin trough.

Looking Ahead

Watch for updates on segment gross margins—especially Medicaid and Medicare duals—Marketplace membership trends, Florida Medicaid contract ramp-up, and clarity on 2027 earnings expectations. As Molina enters earnings season, the firm’s ability to execute on cost discipline and new contract performance will be key to investor confidence heading into 2027.